Experience in assessing the quality of dispensary observation of adults after myocardial infarction in the Central, Ural, Siberian and Far Eastern Federal Districts of the Russian Federation
Dublin Core | PKP Metadata Items | Metadata for this Document | |
1. | Title | Title of document | Experience in assessing the quality of dispensary observation of adults after myocardial infarction in the Central, Ural, Siberian and Far Eastern Federal Districts of the Russian Federation |
2. | Creator | Author's name, affiliation, country | Irina V. Atyunina; Chazov National Medical Research Center of Cardiology; Russian Federation |
2. | Creator | Author's name, affiliation, country | Evgeny V. Sorokin; Chazov National Medical Research Center of Cardiology; Russian Federation |
2. | Creator | Author's name, affiliation, country | Yuliya A. Dolgusheva; Chazov National Medical Research Center of Cardiology; Russian Federation |
3. | Subject | Discipline(s) | |
3. | Subject | Keyword(s) | dispensary observation; continuity of treatment; myocardial infarction; clinical guideline; cardiologist; cardiovascular diseases; diagnostic algorithms |
4. | Description | Abstract | Aim. Тo evaluate the quality of dispensary observation (DO) and treatment after myocardial infarction in accordance with the current DO-algoritm and clinical guidelines (CG). Materials and methods. A questionnaire collection of data of the quality of DO and CG compliance was conducted in 28 regions of the Russian Federation (1241 questionnaires). The quality of DO was assessed according to a number of criteria, including the timing of establishing DO and issuing prescriptions for drugs, the specialty of the doctor performing DO, the frequency of DO-visits and adherence to the diagnostic algorithm, compliance with drug prescriptions current CG. Results. Timely DO, cardiologist's follow up of patients discharged from the hospitall did not take place in all regions. The diagnostic algorithms of DO were generally followed, however, the drug therapy did not fully comply to CG, especially in beta-blockers and drugs that affect the renin-angiotensin system. Conclusion. There is a need for further improvement of the DO of patients with myocardial infarction. The introduction, modernization of additional mechanisms that ensure the continuity and efficiency of the diagnostic, treatment process, and the optimization of drug treatment will improve the quality of outpatient cardiac care and DO. |
5. | Publisher | Organizing agency, location | LLC Obyedinennaya Redaktsiya |
6. | Contributor | Sponsor(s) | |
7. | Date | (DD-MM-YYYY) | 21.02.2025 |
8. | Type | Status & genre | Peer-reviewed Article |
8. | Type | Type | Research Article |
9. | Format | File format | |
10. | Identifier | Uniform Resource Identifier | https://ter-arkhiv.ru/0040-3660/article/view/623168 |
10. | Identifier | Digital Object Identifier (DOI) | 10.26442/00403660.2025.01.203027 |
11. | Source | Title; vol., no. (year) | Terapevticheskii arkhiv; Vol 97, No 1 (2025): Поликлинические проблемы и организация медицинской помощи |
12. | Language | English=en | ru |
13. | Relation | Supp. Files |
Fig. 1. Percentage of patients followed up by a cardiologist/general practitioner, and patients who are promptly enrolled in the follow-up care, %. (474KB) Fig. 2. Percentage of patients with myocardial infarction (MI) discharged from the hospital by the terms of writing prescriptions for fully reimbursed drugs within the Federal Project "Combating Cardiovascular Diseases". (499KB) Fig. 3. Percentage of patients promptly enrolled in the follow-up care, and the percentage of prescriptions written within the required time period, %. (194KB) Fig. 4. Percentage of patients who visited a cardiologist/general practitioner after MI within the given timeframe (at least once in 6 months), %. (197KB) Fig. 5. Percentage of patients who completed diagnostic algorithms (ECG, EchoCG, serial LDL-C), %. (317KB) Fig. 6. Proportion of patients enrolled in follow-up care whose treatment does not comply with clinical guidelines after MI, % (n=1,102). (165KB) |
14. | Coverage | Geo-spatial location, chronological period, research sample (gender, age, etc.) | |
15. | Rights | Copyright and permissions |
Copyright (c) 2025 Consilium Medicum![]() This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. |